Abstract
The Mdm2 and Mdm4 genes are amplified and overexpressed in a variety of human cancers and encode structurally related oncoproteins that bind to the p53 tumor suppressor protein and inhibit p53 activity. Mice deleted for either Mdm2 or Mdm4 die during embryogenesis, and the developmental lethality of either mouse model can be rescued by concomitant deletion of p53. However, the phenotypes of Mdm2 and Mdm4-deficient mice suggest that Mdm2 and Mdm4 play nonoverlapping roles in regulating p53 activity during development, with Mdm2 regulating p53-mediated cell death and Mdm4 regulating p53-mediated inhibition of cell growth. Here, we describe complete rescue of Mdm4-deficient mice by expression of an Mdm2 transgene, and demonstrate that Mdm2 can regulate both p53-mediated apoptosis and inhibition of cell growth in the absence of Mdm4 in primary cells. Furthermore, deletion of Mdm4 enhances the ability of Mdm2 to promote cell growth and tumor formation, indicating that Mdm4 has antioncogenic properties when Mdm2 is overexpressed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW and Jacks T . (2000). Genes Dev., 14, 704–718.
Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ and Lozano G . (2003). Cancer Res., 63, 8664–8669.
Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, Jochemsen AG and Marine JC . (2004). Mol. Cell. Biol., 24, 5835–5843.
de Rozieres S, Maya R, Oren M and Lozano G . (2000). Oncogene, 19, 1691–1697.
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butell JS and Bradley A . (1992). Nature, 356, 215–221.
Finch RA, Donoviel DB, Potter D, Shi M, Fan A, Freed DD, Wang CY, Zambrowicz BP, Ramirez-Solis R, Sands AT and Zhang N . (2002). Cancer Res., 62, 3221–3225.
Gu J, Kawai H, Nie L, Kitao H, Wiederschain D, Jochemsen AG, Parant J, Lozano G and Yuan ZM . (2002). J. Biol. Chem., 277, 19251–19254.
Harvey M, Sands AT, Weissm RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA . (1993). Oncogene, 8, 2457–2467.
Jackson MW and Berberich SJ . (2000). Mol. Cell. Biol., 20, 1001–1007.
Jones SN, Hancock AR, Vogel H, Donehower LA and Bradley A . (1998). Proc. Natl. Acad. Sci. USA, 95, 15608–15612.
Jones SN, Roe AE, Donehower LA and Bradley A . (1995). Nature, 378, 206–208.
Jones SN, Sands AT, Hancock AR, Vogel H, Donehower LA, Linke SP, Wahl GM and Bradley A . (1996). Proc. Natl. Acad. Sci. USA, 93, 14106–14111.
Mancini F, Gentiletti F, D'Angelo M, Giglio S, Nanni S, D'Angelo C, Farsetti A, Citro G, Sacchi A, Pontecorvi A and Moretti F . (2004). J. Biol. Chem., 279, 8169–8180.
Michael D and Oren M . (2002). Curr. Opin. Genet. Dev., 12, 53–59.
Migliorini D, Denchi EL, Danovi D, Jochemsen A, Capillo M, Gobbi A, Helin K, Pelicci PG and Marine JC . (2002). Mol. Cell. Biol., 22, 5527–5538.
Montes de Oca Luna R, Amelse LL, Chavez-Reyes A, Evans SC, Brugarolas J, Jacks T and Lozano G . (1997). Nat. Genet., 16, 336–337.
Montes de Oca Luna R, Wagner DS and Lozano G . (1995). Nature, 378, 203–206.
Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B . (1992). Nature, 358, 15–16.
Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG and Lozano G . (2001). Nat. Genet., 29, 92–95.
Sharp DA, Kratowicz SA, Sank MJ and George DL . (1999). J. Biol. Chem., 274, 38189–38196.
Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt W, Hateboer G, van der Eb AJ and Jochemsen AG . (1996). EMBO J., 15, 5349–5357.
Stad R, Little NA, Xirodimas DP, Frenk R, van der Eb AJ, Lane DP, Saville MK and Jochemsen AG . (2001). EMBO Rep., 2, 1029–1034.
Stad R, Ramos YF, Little N, Grivell S, Attema J, van Der Eb AJ and Jochemsen AG . (2000). J. Biol. Chem., 275, 28039–28044.
Steinman HA and Jones SN . (2002). Genesis, 32, 142–144.
Steinman HA, Sluss HK, Sands AT, Pihan G and Jones SN . (2004). Oncogene, 23, 303–306.
Vousden KH . (2000). Cell, 103, 691–694.
Woods DB and Vousden KH . (2001). Exp. Cell Res., 264, 56–66.
Acknowledgements
We thank Scott Lowe for providing the pLPC-12sE1A vector, Christopher Lengner for technical assistance with real-time PCR, and Charlene Baron for assistance with manuscript preparation. This work was supported by a grant (CA77735) from the National Institutes of Health to SNJ.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steinman, H., Hoover, K., Keeler, M. et al. Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development. Oncogene 24, 7935–7940 (2005). https://doi.org/10.1038/sj.onc.1208930
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208930
Keywords
This article is cited by
-
MDM2 oligomers: antagonizers of the guardian of the genome
Oncogene (2016)
-
Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish
Oncogene (2015)
-
Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity
Oncogene (2015)
-
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway
The EMBO Journal (2009)
-
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Nature Reviews Cancer (2006)